These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 32638368

  • 1. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.
    Tawil S, Irani C, Kfoury R, Salameh P, Baiardini I, Weller K, Maurer M, Ezzedine K.
    Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368
    [Abstract] [Full Text] [Related]

  • 2. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Dhabal A, Mondal H, Mondal S, Baiardini I, Chakraborty SS, Chakraborty T, Podder I.
    Indian J Dermatol Venereol Leprol; 2023 Aug; 89(3):385-392. PubMed ID: 36331856
    [Abstract] [Full Text] [Related]

  • 3. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL).
    Ferreira PL, Gonçalo M, Ferreira JA, Costa AC, Todo-Bom A, Abreu CL, Travassos AR, Andrade P, Baiardini I, Canonica GW.
    Health Qual Life Outcomes; 2019 Dec 30; 17(1):190. PubMed ID: 31888747
    [Abstract] [Full Text] [Related]

  • 4. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.
    Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Dabbaghzade A, Tavakol Z, Afarideh M, Rezaei N.
    Iran J Allergy Asthma Immunol; 2014 Aug 30; 13(4):278-85. PubMed ID: 24659164
    [Abstract] [Full Text] [Related]

  • 5. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kulthanan K, Chularojanamontri L, Tuchinda P, Rujitharanawong C, Baiardini I, Braido F.
    Asian Pac J Allergy Immunol; 2016 Jun 30; 34(2):137-45. PubMed ID: 27007835
    [Abstract] [Full Text] [Related]

  • 6. Chinese version of the chronic urticaria quality of life questionnaire: cultural adaptation, factor analysis, assessment of reliability and validity.
    Zhao Z, Zhang C, Jiang Y, Peng C, Zhu W, Zhao S, Chen X, Li J.
    Arch Dermatol Res; 2022 Nov 30; 314(9):847-855. PubMed ID: 34739561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I, Gimenez-Arnau A, Bartra J, Labrador-Horrillo M, de Frutos JO, Silvestre JF, Sastre J, Velasco M, Ferrer M, Ballesteros C, Valero A.
    Health Qual Life Outcomes; 2019 Jan 31; 17(1):23. PubMed ID: 30704532
    [Abstract] [Full Text] [Related]

  • 9. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, del Cuvillo A, Montoro J, Mullol J, Sastre J, Canonica GW, Baiardini I.
    J Investig Allergol Clin Immunol; 2008 Jan 31; 18(6):426-32. PubMed ID: 19123433
    [Abstract] [Full Text] [Related]

  • 10. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
    Salman A, Demir G, Bekiroglu N.
    Dermatol Ther; 2019 Jul 31; 32(4):e12975. PubMed ID: 31145524
    [Abstract] [Full Text] [Related]

  • 11. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
    Koti I, Weller K, Makris M, Tiligada E, Psaltopoulou T, Papageorgiou C, Baiardini I, Panagiotakos D, Braido F, Maurer M.
    Dermatology; 2013 Jul 31; 226(4):371-9. PubMed ID: 23942323
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
    Kolkhir P, Laires PA, Salameh P, Asero R, Bizjak M, Košnik M, Dissemond J, van Doorn M, Hawro T, Kasperska-Zajac A, Zajac M, Kocatürk E, Peter J, Parisi CAS, Ritchie CA, Kulthanan K, Tuchinda P, Fomina D, Kovalkova E, Khoshkhui M, Kouzegaran S, Papapostolou N, Du-Thanh A, Kamegashira A, Meshkova R, Vitchuk A, Bauer A, Grattan C, Staubach P, Bouillet L, Giménez-Arnau AM, Maurer M, Weller K.
    J Allergy Clin Immunol Pract; 2023 Feb 31; 11(2):610-620.e5. PubMed ID: 36481420
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
    Kitsioulis NA, Xepapadaki P, Roussaki-Schulze AV, Papadopoulos N, Zafiriou E.
    Int Arch Allergy Immunol; 2017 Feb 31; 172(3):161-166. PubMed ID: 28380487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
    Rossi O, Piccirillo A, Iemoli E, Patrizi A, Stingeni L, Calvieri S, Gola M, Dapavo P, Cristaudo A, Zichichi L, Losappio L, Saccheri F, Pastorello EA.
    World Allergy Organ J; 2020 Dec 31; 13(12):100470. PubMed ID: 33343800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.